Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

September 01, 2013; Volume 41,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Barbier, Olivier

    1. You have access
      The Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation
      Martin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, Mélanie Verreault, Patrick Caron, Moshe Finel and Olivier Barbier
      Drug Metabolism and Disposition September 2013, 41 (9) 1616-1620; DOI: https://doi.org/10.1124/dmd.113.052613
  2. Barbuch, Robert J.

    1. You have access
      The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
      Ariel R. Topletz, Jennifer B. Dennison, Robert J. Barbuch, Chad E. Hadden, Stephen D. Hall and Jamie L. Renbarger
      Drug Metabolism and Disposition September 2013, 41 (9) 1651-1661; DOI: https://doi.org/10.1124/dmd.113.051094
  3. Bergström, Helena

    1. You have access
      Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver
      Linda Björkhem-Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane and Lena Ekström
      Drug Metabolism and Disposition September 2013, 41 (9) 1610-1615; DOI: https://doi.org/10.1124/dmd.113.051698
  4. Bernstein, Hilary J.

    1. You have access
      An Assessment of Pharmacokinetics and Antioxidant Activity of Free Silymarin Flavonolignans in Healthy Volunteers: A Dose Escalation Study
      Hao-Jie Zhu, Bryan J. Brinda, Kenneth D. Chavin, Hilary J. Bernstein, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition September 2013, 41 (9) 1679-1685; DOI: https://doi.org/10.1124/dmd.113.052423
  5. Björkhem-Bergman, Linda

    1. You have access
      Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver
      Linda Björkhem-Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane and Lena Ekström
      Drug Metabolism and Disposition September 2013, 41 (9) 1610-1615; DOI: https://doi.org/10.1124/dmd.113.051698
  6. Brantley, Scott J.

    1. You have access
      A Systematic Approach to Evaluate Herb-Drug Interaction Mechanisms: Investigation of Milk Thistle Extracts and Eight Isolated Constituents as CYP3A Inhibitors
      Scott J. Brantley, Tyler N. Graf, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2013, 41 (9) 1662-1670; DOI: https://doi.org/10.1124/dmd.113.052563
  7. Bridges, Arlene S.

    1. You have access
      Intestinal First-Pass Metabolism by Cytochrome P450 and Not P-Glycoprotein Is the Major Barrier to Amprenavir Absorption
      Matthew B. Dufek, Arlene S. Bridges and Dhiren R. Thakker
      Drug Metabolism and Disposition September 2013, 41 (9) 1695-1702; DOI: https://doi.org/10.1124/dmd.113.052191
  8. Bridges, Thomas M.

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084
  9. Brinda, Bryan J.

    1. You have access
      An Assessment of Pharmacokinetics and Antioxidant Activity of Free Silymarin Flavonolignans in Healthy Volunteers: A Dose Escalation Study
      Hao-Jie Zhu, Bryan J. Brinda, Kenneth D. Chavin, Hilary J. Bernstein, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition September 2013, 41 (9) 1679-1685; DOI: https://doi.org/10.1124/dmd.113.052423

C

  1. Carcache, David

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  2. Caron, Patrick

    1. You have access
      The Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation
      Martin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, Mélanie Verreault, Patrick Caron, Moshe Finel and Olivier Barbier
      Drug Metabolism and Disposition September 2013, 41 (9) 1616-1620; DOI: https://doi.org/10.1124/dmd.113.052613
  3. Chakraborty, Abhijit

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  4. Chavin, Kenneth D.

    1. You have access
      An Assessment of Pharmacokinetics and Antioxidant Activity of Free Silymarin Flavonolignans in Healthy Volunteers: A Dose Escalation Study
      Hao-Jie Zhu, Bryan J. Brinda, Kenneth D. Chavin, Hilary J. Bernstein, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition September 2013, 41 (9) 1679-1685; DOI: https://doi.org/10.1124/dmd.113.052423
  5. Cherrington, Nathan J.

    1. You have access
      Downregulation of Sulfotransferase Expression and Activity in Diseased Human Livers
      Emine B. Yalcin, Vijay More, Karissa L. Neira, Zhenqiang James Lu, Nathan J. Cherrington, Angela L. Slitt and Roberta S. King
      Drug Metabolism and Disposition September 2013, 41 (9) 1642-1650; DOI: https://doi.org/10.1124/dmd.113.050930
  6. Cohen-Wolkowiez, Michael

    1. You have access
      The Role of Human Cytochrome P450 Enzymes in the Formation of 2-Hydroxymetronidazole: CYP2A6 is the High Affinity (Low Km) Catalyst
      Robin E. Pearce, Michael Cohen-Wolkowiez, Mario R. Sampson and Gregory L. Kearns
      Drug Metabolism and Disposition September 2013, 41 (9) 1686-1694; DOI: https://doi.org/10.1124/dmd.113.052548
  7. Conn, P. Jeffrey

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084
  8. Cushman, Mark

    1. You have access
      Inhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of Norendoxifen
      Jinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. Flockhart
      Drug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506

D

  1. Dallas, Shannon

    1. You have access
      Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
      Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei Zhang
      Drug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
  2. Daniels, J. Scott

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084
  3. Dennison, Jennifer B.

    1. You have access
      The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
      Ariel R. Topletz, Jennifer B. Dennison, Robert J. Barbuch, Chad E. Hadden, Stephen D. Hall and Jamie L. Renbarger
      Drug Metabolism and Disposition September 2013, 41 (9) 1651-1661; DOI: https://doi.org/10.1124/dmd.113.051094
  4. Dickmann, Leslie J.

    1. You have access
      Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
      Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei Zhang
      Drug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
  5. Dufek, Matthew B.

    1. You have access
      Intestinal First-Pass Metabolism by Cytochrome P450 and Not P-Glycoprotein Is the Major Barrier to Amprenavir Absorption
      Matthew B. Dufek, Arlene S. Bridges and Dhiren R. Thakker
      Drug Metabolism and Disposition September 2013, 41 (9) 1695-1702; DOI: https://doi.org/10.1124/dmd.113.052191

E

  1. Ekström, Lena

    1. You have access
      Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver
      Linda Björkhem-Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane and Lena Ekström
      Drug Metabolism and Disposition September 2013, 41 (9) 1610-1615; DOI: https://doi.org/10.1124/dmd.113.051698
  2. Eriksson, Mats

    1. You have access
      Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver
      Linda Björkhem-Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane and Lena Ekström
      Drug Metabolism and Disposition September 2013, 41 (9) 1610-1615; DOI: https://doi.org/10.1124/dmd.113.051698
  3. Evers, Raymond

    1. You have access
      Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
      Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei Zhang
      Drug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225

F

  1. Fahmi, Odette A.

    1. You have access
      Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
      Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei Zhang
      Drug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
  2. Finel, Moshe

    1. You have access
      The Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation
      Martin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, Mélanie Verreault, Patrick Caron, Moshe Finel and Olivier Barbier
      Drug Metabolism and Disposition September 2013, 41 (9) 1616-1620; DOI: https://doi.org/10.1124/dmd.113.052613
  3. Flockhart, David A.

    1. You have access
      Inhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of Norendoxifen
      Jinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. Flockhart
      Drug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506
  4. Flockhart, Peter J.

    1. You have access
      Inhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of Norendoxifen
      Jinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. Flockhart
      Drug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506

G

  1. Gauthier-Landry, Louis

    1. You have access
      The Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation
      Martin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, Mélanie Verreault, Patrick Caron, Moshe Finel and Olivier Barbier
      Drug Metabolism and Disposition September 2013, 41 (9) 1616-1620; DOI: https://doi.org/10.1124/dmd.113.052613
  2. Gogliotti, Rocco D.

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084
  3. Graf, Tyler N.

    1. You have access
      A Systematic Approach to Evaluate Herb-Drug Interaction Mechanisms: Investigation of Milk Thistle Extracts and Eight Isolated Constituents as CYP3A Inhibitors
      Scott J. Brantley, Tyler N. Graf, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2013, 41 (9) 1662-1670; DOI: https://doi.org/10.1124/dmd.113.052563
  4. Gschwind, Hans-Peter

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716

H

  1. Hadden, Chad E.

    1. You have access
      The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
      Ariel R. Topletz, Jennifer B. Dennison, Robert J. Barbuch, Chad E. Hadden, Stephen D. Hall and Jamie L. Renbarger
      Drug Metabolism and Disposition September 2013, 41 (9) 1651-1661; DOI: https://doi.org/10.1124/dmd.113.051094
  2. Hall, Stephen D.

    1. You have access
      The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
      Ariel R. Topletz, Jennifer B. Dennison, Robert J. Barbuch, Chad E. Hadden, Stephen D. Hall and Jamie L. Renbarger
      Drug Metabolism and Disposition September 2013, 41 (9) 1651-1661; DOI: https://doi.org/10.1124/dmd.113.051094
  3. Han, Xu

    1. You have access
      Inhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of Norendoxifen
      Jinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. Flockhart
      Drug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506

J

  1. Jin, Yi

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  2. Johansson, Maria

    1. You have access
      Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver
      Linda Björkhem-Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane and Lena Ekström
      Drug Metabolism and Disposition September 2013, 41 (9) 1610-1615; DOI: https://doi.org/10.1124/dmd.113.051698
  3. Jones, Carrie K.

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084

K

  1. Kearns, Gregory L.

    1. You have access
      The Role of Human Cytochrome P450 Enzymes in the Formation of 2-Hydroxymetronidazole: CYP2A6 is the High Affinity (Low Km) Catalyst
      Robin E. Pearce, Michael Cohen-Wolkowiez, Mario R. Sampson and Gregory L. Kearns
      Drug Metabolism and Disposition September 2013, 41 (9) 1686-1694; DOI: https://doi.org/10.1124/dmd.113.052548
  2. Kenny, Jane R.

    1. You have access
      Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
      Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei Zhang
      Drug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
  3. King, Roberta S.

    1. You have access
      Downregulation of Sulfotransferase Expression and Activity in Diseased Human Livers
      Emine B. Yalcin, Vijay More, Karissa L. Neira, Zhenqiang James Lu, Nathan J. Cherrington, Angela L. Slitt and Roberta S. King
      Drug Metabolism and Disposition September 2013, 41 (9) 1642-1650; DOI: https://doi.org/10.1124/dmd.113.050930
  4. Kittelmann, Matthias

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  5. Krauser, Joel

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  6. Kraynov, Eugenia

    1. You have access
      Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
      Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei Zhang
      Drug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
  7. Kunori, Mutsuki

    1. You have access
      Characterization of Microsomal Glutathione S-Transferases MGST1, MGST2, and MGST3 in Cynomolgus Macaque
      Yasuhiro Uno, Norie Murayama, Mutsuki Kunori and Hiroshi Yamazaki
      Drug Metabolism and Disposition September 2013, 41 (9) 1621-1625; DOI: https://doi.org/10.1124/dmd.113.052977

L

  1. Lavery, Gareth G.

    1. You have access
      Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1
      Arne Meyer, Anna Vuorinen, Agnieszka E. Zielinska, Petra Strajhar, Gareth G. Lavery, Daniela Schuster and Alex Odermatt
      Drug Metabolism and Disposition September 2013, 41 (9) 1671-1678; DOI: https://doi.org/10.1124/dmd.113.052936
  2. Leuthold, Luc Alexis

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  3. Lindsley, Craig W.

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084
  4. Liu, Jinzhong

    1. You have access
      Inhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of Norendoxifen
      Jinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. Flockhart
      Drug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506
  5. Lu, Deshun

    1. You have access
      Inhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of Norendoxifen
      Jinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. Flockhart
      Drug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506
  6. Lu, Wenjie Jessie

    1. You have access
      Inhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of Norendoxifen
      Jinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. Flockhart
      Drug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506
  7. Lu, Zhenqiang James

    1. You have access
      Downregulation of Sulfotransferase Expression and Activity in Diseased Human Livers
      Emine B. Yalcin, Vijay More, Karissa L. Neira, Zhenqiang James Lu, Nathan J. Cherrington, Angela L. Slitt and Roberta S. King
      Drug Metabolism and Disposition September 2013, 41 (9) 1642-1650; DOI: https://doi.org/10.1124/dmd.113.050930
  8. Lv, Wei

    1. You have access
      Inhibition of Cytochrome P450 Enzymes by the E- and Z-Isomers of Norendoxifen
      Jinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman and David A. Flockhart
      Drug Metabolism and Disposition September 2013, 41 (9) 1715-1720; DOI: https://doi.org/10.1124/dmd.113.052506

M

  1. Markowitz, John S.

    1. You have access
      An Assessment of Pharmacokinetics and Antioxidant Activity of Free Silymarin Flavonolignans in Healthy Volunteers: A Dose Escalation Study
      Hao-Jie Zhu, Bryan J. Brinda, Kenneth D. Chavin, Hilary J. Bernstein, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition September 2013, 41 (9) 1679-1685; DOI: https://doi.org/10.1124/dmd.113.052423
  2. Meyer, Arne

    1. You have access
      Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1
      Arne Meyer, Anna Vuorinen, Agnieszka E. Zielinska, Petra Strajhar, Gareth G. Lavery, Daniela Schuster and Alex Odermatt
      Drug Metabolism and Disposition September 2013, 41 (9) 1671-1678; DOI: https://doi.org/10.1124/dmd.113.052936
  3. More, Vijay

    1. You have access
      Downregulation of Sulfotransferase Expression and Activity in Diseased Human Livers
      Emine B. Yalcin, Vijay More, Karissa L. Neira, Zhenqiang James Lu, Nathan J. Cherrington, Angela L. Slitt and Roberta S. King
      Drug Metabolism and Disposition September 2013, 41 (9) 1642-1650; DOI: https://doi.org/10.1124/dmd.113.050930
  4. Morrison, Ryan D.

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084
  5. Murayama, Norie

    1. You have access
      Characterization of Microsomal Glutathione S-Transferases MGST1, MGST2, and MGST3 in Cynomolgus Macaque
      Yasuhiro Uno, Norie Murayama, Mutsuki Kunori and Hiroshi Yamazaki
      Drug Metabolism and Disposition September 2013, 41 (9) 1621-1625; DOI: https://doi.org/10.1124/dmd.113.052977

N

  1. Neira, Karissa L.

    1. You have access
      Downregulation of Sulfotransferase Expression and Activity in Diseased Human Livers
      Emine B. Yalcin, Vijay More, Karissa L. Neira, Zhenqiang James Lu, Nathan J. Cherrington, Angela L. Slitt and Roberta S. King
      Drug Metabolism and Disposition September 2013, 41 (9) 1642-1650; DOI: https://doi.org/10.1124/dmd.113.050930
  2. Nguyen, Theresa

    1. You have access
      Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
      Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei Zhang
      Drug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
  3. Niswender, Colleen M.

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084
  4. Noetzel, Meredith J.

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084

O

  1. Oberlies, Nicholas H.

    1. You have access
      A Systematic Approach to Evaluate Herb-Drug Interaction Mechanisms: Investigation of Milk Thistle Extracts and Eight Isolated Constituents as CYP3A Inhibitors
      Scott J. Brantley, Tyler N. Graf, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2013, 41 (9) 1662-1670; DOI: https://doi.org/10.1124/dmd.113.052563
  2. Ocwieja, Magdalena

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  3. Odermatt, Alex

    1. You have access
      Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1
      Arne Meyer, Anna Vuorinen, Agnieszka E. Zielinska, Petra Strajhar, Gareth G. Lavery, Daniela Schuster and Alex Odermatt
      Drug Metabolism and Disposition September 2013, 41 (9) 1671-1678; DOI: https://doi.org/10.1124/dmd.113.052936

P

  1. Paine, Mary F.

    1. You have access
      A Systematic Approach to Evaluate Herb-Drug Interaction Mechanisms: Investigation of Milk Thistle Extracts and Eight Isolated Constituents as CYP3A Inhibitors
      Scott J. Brantley, Tyler N. Graf, Nicholas H. Oberlies and Mary F. Paine
      Drug Metabolism and Disposition September 2013, 41 (9) 1662-1670; DOI: https://doi.org/10.1124/dmd.113.052563
  2. Parini, Paolo

    1. You have access
      Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver
      Linda Björkhem-Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane and Lena Ekström
      Drug Metabolism and Disposition September 2013, 41 (9) 1610-1615; DOI: https://doi.org/10.1124/dmd.113.051698
  3. Patel, Aarti H.

    1. You have access
      Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
      Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei Zhang
      Drug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
  4. Patrick, Kennerly S.

    1. You have access
      An Assessment of Pharmacokinetics and Antioxidant Activity of Free Silymarin Flavonolignans in Healthy Volunteers: A Dose Escalation Study
      Hao-Jie Zhu, Bryan J. Brinda, Kenneth D. Chavin, Hilary J. Bernstein, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition September 2013, 41 (9) 1679-1685; DOI: https://doi.org/10.1124/dmd.113.052423
  5. Pearce, Robin E.

    1. You have access
      The Role of Human Cytochrome P450 Enzymes in the Formation of 2-Hydroxymetronidazole: CYP2A6 is the High Affinity (Low Km) Catalyst
      Robin E. Pearce, Michael Cohen-Wolkowiez, Mario R. Sampson and Gregory L. Kearns
      Drug Metabolism and Disposition September 2013, 41 (9) 1686-1694; DOI: https://doi.org/10.1124/dmd.113.052548
  6. Perreault, Martin

    1. You have access
      The Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation
      Martin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, Mélanie Verreault, Patrick Caron, Moshe Finel and Olivier Barbier
      Drug Metabolism and Disposition September 2013, 41 (9) 1616-1620; DOI: https://doi.org/10.1124/dmd.113.052613

R

  1. Rane, Anders

    1. You have access
      Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver
      Linda Björkhem-Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane and Lena Ekström
      Drug Metabolism and Disposition September 2013, 41 (9) 1610-1615; DOI: https://doi.org/10.1124/dmd.113.051698
  2. Renbarger, Jamie L.

    1. You have access
      The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
      Ariel R. Topletz, Jennifer B. Dennison, Robert J. Barbuch, Chad E. Hadden, Stephen D. Hall and Jamie L. Renbarger
      Drug Metabolism and Disposition September 2013, 41 (9) 1651-1661; DOI: https://doi.org/10.1124/dmd.113.051094
  3. Ritzau, Michael

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  4. Rook, Jerri M.

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084

S

  1. Sampson, Mario R.

    1. You have access
      The Role of Human Cytochrome P450 Enzymes in the Formation of 2-Hydroxymetronidazole: CYP2A6 is the High Affinity (Low Km) Catalyst
      Robin E. Pearce, Michael Cohen-Wolkowiez, Mario R. Sampson and Gregory L. Kearns
      Drug Metabolism and Disposition September 2013, 41 (9) 1686-1694; DOI: https://doi.org/10.1124/dmd.113.052548
  2. Schuster, Daniela

    1. You have access
      Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1
      Arne Meyer, Anna Vuorinen, Agnieszka E. Zielinska, Petra Strajhar, Gareth G. Lavery, Daniela Schuster and Alex Odermatt
      Drug Metabolism and Disposition September 2013, 41 (9) 1671-1678; DOI: https://doi.org/10.1124/dmd.113.052936
  3. Slatter, J. Greg

    1. You have access
      Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
      Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei Zhang
      Drug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
  4. Slitt, Angela L.

    1. You have access
      Downregulation of Sulfotransferase Expression and Activity in Diseased Human Livers
      Emine B. Yalcin, Vijay More, Karissa L. Neira, Zhenqiang James Lu, Nathan J. Cherrington, Angela L. Slitt and Roberta S. King
      Drug Metabolism and Disposition September 2013, 41 (9) 1642-1650; DOI: https://doi.org/10.1124/dmd.113.050930
  5. Stauffer, Shaun R.

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084
  6. Strajhar, Petra

    1. You have access
      Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1
      Arne Meyer, Anna Vuorinen, Agnieszka E. Zielinska, Petra Strajhar, Gareth G. Lavery, Daniela Schuster and Alex Odermatt
      Drug Metabolism and Disposition September 2013, 41 (9) 1671-1678; DOI: https://doi.org/10.1124/dmd.113.052936
  7. Swart, Piet

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716

T

  1. Thakker, Dhiren R.

    1. You have access
      Intestinal First-Pass Metabolism by Cytochrome P450 and Not P-Glycoprotein Is the Major Barrier to Amprenavir Absorption
      Matthew B. Dufek, Arlene S. Bridges and Dhiren R. Thakker
      Drug Metabolism and Disposition September 2013, 41 (9) 1695-1702; DOI: https://doi.org/10.1124/dmd.113.052191
  2. Topletz, Ariel R.

    1. You have access
      The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
      Ariel R. Topletz, Jennifer B. Dennison, Robert J. Barbuch, Chad E. Hadden, Stephen D. Hall and Jamie L. Renbarger
      Drug Metabolism and Disposition September 2013, 41 (9) 1651-1661; DOI: https://doi.org/10.1124/dmd.113.051094
  3. Trottier, Jocelyn

    1. You have access
      The Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation
      Martin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, Mélanie Verreault, Patrick Caron, Moshe Finel and Olivier Barbier
      Drug Metabolism and Disposition September 2013, 41 (9) 1616-1620; DOI: https://doi.org/10.1124/dmd.113.052613

U

  1. Ufer, Mike

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  2. Uno, Yasuhiro

    1. You have access
      Characterization of Microsomal Glutathione S-Transferases MGST1, MGST2, and MGST3 in Cynomolgus Macaque
      Yasuhiro Uno, Norie Murayama, Mutsuki Kunori and Hiroshi Yamazaki
      Drug Metabolism and Disposition September 2013, 41 (9) 1621-1625; DOI: https://doi.org/10.1124/dmd.113.052977

V

  1. Verreault, Mélanie

    1. You have access
      The Human UDP-Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation
      Martin Perreault, Louis Gauthier-Landry, Jocelyn Trottier, Mélanie Verreault, Patrick Caron, Moshe Finel and Olivier Barbier
      Drug Metabolism and Disposition September 2013, 41 (9) 1616-1620; DOI: https://doi.org/10.1124/dmd.113.052613
  2. Vinson, Paige N.

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084
  3. Vuorinen, Anna

    1. You have access
      Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1
      Arne Meyer, Anna Vuorinen, Agnieszka E. Zielinska, Petra Strajhar, Gareth G. Lavery, Daniela Schuster and Alex Odermatt
      Drug Metabolism and Disposition September 2013, 41 (9) 1671-1678; DOI: https://doi.org/10.1124/dmd.113.052936

W

  1. Walles, Markus

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  2. Woessner, Ralph

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716
  3. Wolf, Thierry

    1. You have access
      Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
      Markus Walles, Thierry Wolf, Yi Jin, Michael Ritzau, Luc Alexis Leuthold, Joel Krauser, Hans-Peter Gschwind, David Carcache, Matthias Kittelmann, Magdalena Ocwieja, Mike Ufer, Ralph Woessner, Abhijit Chakraborty and Piet Swart
      Drug Metabolism and Disposition September 2013, 41 (9) 1626-1641; DOI: https://doi.org/10.1124/dmd.112.050716

X

  1. Xiang, Zixiu

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084

Y

  1. Yalcin, Emine B.

    1. You have access
      Downregulation of Sulfotransferase Expression and Activity in Diseased Human Livers
      Emine B. Yalcin, Vijay More, Karissa L. Neira, Zhenqiang James Lu, Nathan J. Cherrington, Angela L. Slitt and Roberta S. King
      Drug Metabolism and Disposition September 2013, 41 (9) 1642-1650; DOI: https://doi.org/10.1124/dmd.113.050930
  2. Yamazaki, Hiroshi

    1. You have access
      Characterization of Microsomal Glutathione S-Transferases MGST1, MGST2, and MGST3 in Cynomolgus Macaque
      Yasuhiro Uno, Norie Murayama, Mutsuki Kunori and Hiroshi Yamazaki
      Drug Metabolism and Disposition September 2013, 41 (9) 1621-1625; DOI: https://doi.org/10.1124/dmd.113.052977

Z

  1. Zhang, Lei

    1. You have access
      Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper
      Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter and Lei Zhang
      Drug Metabolism and Disposition September 2013, 41 (9) 1598-1609; DOI: https://doi.org/10.1124/dmd.113.052225
  2. Zhou, Ya

    1. You have access
      Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism
      Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang, Carrie K. Jones, Colleen M. Niswender, Craig W. Lindsley, Shaun R. Stauffer, P. Jeffrey Conn and J. Scott Daniels
      Drug Metabolism and Disposition September 2013, 41 (9) 1703-1714; DOI: https://doi.org/10.1124/dmd.113.052084
  3. Zhu, Hao-Jie

    1. You have access
      An Assessment of Pharmacokinetics and Antioxidant Activity of Free Silymarin Flavonolignans in Healthy Volunteers: A Dose Escalation Study
      Hao-Jie Zhu, Bryan J. Brinda, Kenneth D. Chavin, Hilary J. Bernstein, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition September 2013, 41 (9) 1679-1685; DOI: https://doi.org/10.1124/dmd.113.052423
  4. Zielinska, Agnieszka E.

    1. You have access
      Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1
      Arne Meyer, Anna Vuorinen, Agnieszka E. Zielinska, Petra Strajhar, Gareth G. Lavery, Daniela Schuster and Alex Odermatt
      Drug Metabolism and Disposition September 2013, 41 (9) 1671-1678; DOI: https://doi.org/10.1124/dmd.113.052936
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 41 (9)
Drug Metabolism and Disposition
Vol. 41, Issue 9
1 Sep 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Metabolism and Disposition of Volanesorsen across Species
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics